IL17A and psoriasis: Given that anti-TNF and anti-IL-17A therapies have shown high efficacy in treating psoriasis, our findings support the rationale for further investigation into the mechanistic roles of these novel genes within the cytokine-regulatory axis, as well as their utility in improving patient stratification and guiding personalized treatment strategies (Gupta et al., 2021).